tryptophan and B-Cell Lymphoma

tryptophan has been researched along with B-Cell Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fan, D; Lu, Y; Xiong, D; Yang, Y; Ye, Z; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y	1

Other Studies

1 other study(ies) available for tryptophan and B-Cell Lymphoma

Article	Year
Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor D-1-methyl-tryptophan. Journal of hematology & oncology, 2017, 02-23, Volume: 10, Issue:1 Topics: Animals; Antibodies, Bispecific; Antibodies, Neoplasm; Antibody-Dependent Cell Cytotoxicity; Antigens, CD19; CD3 Complex; Cell Line; Cell Line, Tumor; HEK293 Cells; Heterografts; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; K562 Cells; Lymphoma, B-Cell; Mesenchymal Stem Cells; Mice; Single-Chain Antibodies; T-Lymphocytes; Tryptophan	2017

Article

Year

Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor D-1-methyl-tryptophan.

Journal of hematology & oncology, 2017, 02-23, Volume: 10, Issue:1

Topics: Animals; Antibodies, Bispecific; Antibodies, Neoplasm; Antibody-Dependent Cell Cytotoxicity; Antigens, CD19; CD3 Complex; Cell Line; Cell Line, Tumor; HEK293 Cells; Heterografts; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; K562 Cells; Lymphoma, B-Cell; Mesenchymal Stem Cells; Mice; Single-Chain Antibodies; T-Lymphocytes; Tryptophan

2017